Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.(QUIT)の株式分析

$6.060

-0.249 (-4.11%)終値時点

Loading chart…
高値
6.330
始値
6.160
出来高加重平均価格
6.14
出来高
822.53K
時価総額
—
安値
6.037
売買代金
5.05M
EV/EBITDA(TTM)
0.00

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

AI分析 of Achieve Life Sciences, Inc. (QUIT)

買い

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

バリュエーション指標

Achieve Life Sciences, Inc.(QUIT)の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E
現在のP/E
0.00

予想EV/EBITDA

5年平均 EV/EBITDA
現在のEV/EBITDA
0.00

予想PSR

大幅な割安
5年平均 P/S
20.19
現在のP/S
20.19
割高
20.19
割安
20.19

QUIT を保有するクジラ

T

TPG Capital, L.P.

+ を保有QUIT

+27.03%

3か月リターン

L

Logos Global Management, L.P.

+ を保有QUIT

+24.07%

3か月リターン

P

Paradigm Biocapital Advisors LP

+ を保有QUIT

+19.24%

3か月リターン

F

Frazier Life Sciences Management, LP

+ を保有QUIT

+10.54%

3か月リターン

V

VR Management, LLC

+ を保有QUIT

+9.81%

3か月リターン

QUIT のよくある質問 — Alphio AI が回答

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める